Want to see TSE:MLCO full AI Analyst Report?
MLCO Stock Chart & Stats
C$0.08
<C$0.01(6.67%)
At close: 4:00 PM EDT
C$0.08
<C$0.01(6.67%)
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.11
Previous CloseN/A
VolumeN/A
Average Volume (3M)171.53K
Market Cap
C$27.42M
Enterprise ValueC$31.73
Total Cash (Recent Filing)C$334.00K
Total Debt (Recent Filing)C$403.00K
Price to Earnings (P/E)―
Beta-0.80
Next Earnings
Nov 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding457,002,000
10 Day Avg. Volume75,023
30 Day Avg. Volume171,525
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)-199.92
Price to Sales (P/S)433.67
P/FCF Ratio-13.33
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
2026 Revenue ReboundThe sharp 2026 revenue rebound indicates some renewed commercial activity after periods that included zero revenue. Although the absolute base remains very small, continued top-line improvement could broaden operating leverage and provide a foundation for future product or market development.
Narrower Net LossesA material reduction in net losses shows that the company’s financial performance improved from the exceptionally weak levels of prior years. If sustained, this trend could reduce funding pressure, preserve capital for development, and move the business incrementally closer to break-even.
Improved Cash BurnLower operating and free-cash-flow outflows in 2026 are a constructive change because they indicate reduced cash consumption relative to the prior year. Sustaining this improvement would extend financial runway and make future progress less dependent on immediate external funding.
Bears Say
Small, Volatile Revenue BaseThe company lacks a demonstrated, dependable revenue engine, with very small sales and a history that includes periods of zero revenue. This volatility makes planning difficult, limits operating leverage, and leaves future performance highly dependent on successfully establishing consistent commercial demand.
Persistent Cash OutflowsPersistent negative operating and free cash flow show that the business is not currently self-funding through operations. Continued cash consumption can constrain investment, increase reliance on financing, and reduce resilience if revenue growth or loss reduction does not continue.
Negative Equity And Smaller Asset BaseNegative equity indicates that accumulated losses have eroded the company’s capital base, while the sharp decline in total assets leaves fewer resources supporting operations. Together, these conditions weaken financial flexibility and make recovery more dependent on rebuilding capital and business scale.
Mountain Valley MD News
MLCO FAQ
What was Mountain Valley MD’s price range in the past 12 months?
Mountain Valley MD lowest stock price was C$0.01 and its highest was C$0.10 in the past 12 months.
What is Mountain Valley MD’s market cap?
Mountain Valley MD’s market cap is C$27.42M.
When is Mountain Valley MD’s upcoming earnings report date?
Mountain Valley MD’s upcoming earnings report date is Nov 26, 2026 which is in 71 days.
How were Mountain Valley MD’s earnings last quarter?
Mountain Valley MD released its earnings results on Jul 28, 2026. The company reported -C$0.004 earnings per share for the quarter.
Is Mountain Valley MD overvalued?
According to Wall Street analysts Mountain Valley MD’s price is currently Overvalued.
Does Mountain Valley MD pay dividends?
Mountain Valley MD does not currently pay dividends.
What is Mountain Valley MD’s EPS estimate?
Mountain Valley MD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mountain Valley MD have?
Mountain Valley MD has 457,002,000 shares outstanding.
What happened to Mountain Valley MD’s price movement after its last earnings report?
Mountain Valley MD reported an EPS of -C$0.004 in its last earnings report. Following the earnings report the stock price went down -13.333%.
Which hedge fund is a major shareholder of Mountain Valley MD?
Currently, no hedge funds are holding shares in TSE:MLCO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mountain Valley MD
The More Life Co. Corp. is a biotechnology company, which engages in the provision of solutions to optimize human, animal, and plant health. Its patented technologies includes Quicksome™ and Quicksol™. The Quicksome™ patented technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into product formats that, if successfully commercialized, could enhance the efficacy of molecule delivery across a variety of nutraceutical product applications. The Quicksol™ patented is a solubilization technology, which has been developed to provide solubilized drug delivery options. The company was founded on March 8, 2005 and is headquartered in Vaughan, Canada.